- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Alternate day iron dosing may increase compliance and efficacy among many women with anemia
Iron deficiency is often treated with daily oral iron supplementation. However, a recent Swiss study published in eClinicalMedicine Lancet challenges this norm, introducing a novel approach with potential benefits.
A recent double-masked, randomized, placebo-controlled trial has challenged traditional guidelines for treating iron deficiency. The study, conducted with 150 young Swiss women with serum ferritin levels below 30 μg/L, compared the effects of consecutive-day versus alternate-day iron supplementation. Participants were assigned to either a consecutive-day group, receiving 100 mg of iron daily for 90 days followed by daily placebos for another 90 days, or an alternate-day group, taking the same daily iron dose on alternate days for a total of 180 days.
At equal total iron doses, the study found that while median serum ferritin levels were comparable between the two groups, the alternate-day dosing regimen demonstrated a remarkable reduction in iron deficiency at the 6-month mark. This novel approach also significantly decreased the prevalence of gastrointestinal side effects associated with iron intake.
The findings challenge the conventional wisdom of daily iron supplementation, suggesting that adopting an alternate-day schedule could be equally effective, if not more so, in certain aspects. Notably, the reduced prevalence of iron deficiency after 6 months is a key highlight, potentially indicating a more sustainable and tolerable approach. The high adherence and meticulous reporting of side effects using a mobile application contribute to the robustness of the results.
While the research offers a promising alternative, it also raises questions about the long-standing practices of daily iron provision. The potential shift toward alternate-day supplementation could mark a significant advancement in optimizing iron therapy for enhanced efficacy and patient comfort.
Source:
von Siebenthal, H. K., Gessler, S., Vallelian, F., Steinwendner, J., Kuenzi, U.-M., Moretti, D., Zimmermann, M. B., & Stoffel, N. U. (2023). Alternate day versus consecutive day oral iron supplementation in iron-depleted women: a randomized double-blind placebo-controlled study. In eClinicalMedicine (Vol. 65, p. 102286). Elsevier BV. https://doi.org/10.1016/j.eclinm.2023.102286
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751